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Abstract
Background: DNA methylation changes at a discrete set of sites in the human genome are predictive of
chronological and biological age. However, it is not known whether these changes are causative or a consequence
of an underlying ageing process. It has also not been shown whether this epigenetic clock is unique to humans or
conserved in the more experimentally tractable mouse.
Results: We have generated a comprehensive set of genome-scale base-resolution methylation maps from multiple
mouse tissues spanning a wide range of ages. Many CpG sites show significant tissue-independent correlations
with age which allowed us to develop a multi-tissue predictor of age in the mouse. Our model, which estimates
age based on DNA methylation at 329 unique CpG sites, has a median absolute error of 3.33 weeks and has similar
properties to the recently described human epigenetic clock. Using publicly available datasets, we find that the
mouse clock is accurate enough to measure effects on biological age, including in the context of interventions.
While females and males show no significant differences in predicted DNA methylation age, ovariectomy results
in significant age acceleration in females. Furthermore, we identify significant differences in age-acceleration
dependent on the lipid content of the diet.
Conclusions: Here we identify and characterise an epigenetic predictor of age in mice, the mouse epigenetic clock.
This clock will be instrumental for understanding the biology of ageing and will allow modulation of its ticking rate
and resetting the clock in vivo to study the impact on biological age.
Keywords: DNA methylation, Epigenetics, Ageing/aging, Ovariectomy, Epigenetic clock, High fat diet, Chronological age,
Biological age, Prediction, Model
Background
Ageing describes the progressive decline in cellular,
tissue and organismal function during life, which ultim-
ately drives age-related diseases and limits lifespan [1].
From a biological perspective, ageing is associated with
numerous changes at the cellular and molecular level
[2], including epigenetic changes, that is modifications of
DNA or chromatin that do not change the primary
nucleotide sequence. At present, it is not clear which
epigenetic changes are causative or correlative, but these
mechanisms are of particular interest due to their
reversibility, suggesting that rejuvenation might be
possible, at least in principle [3, 4].
Recently, age-correlated DNA methylation changes at
discrete sets of CpGs in the human genome have been
identified and used to predict age [5–7]. These ‘epigenetic
clocks’ can estimate the DNA methylation age in specific
tissues [5] or tissue-independently [6] and can predict
mortality [8] and time to death [9]. These findings have
sparked intense interest regarding the role of DNA methy-
lation in the ageing process and also opened up a number
of key questions. Interestingly, while initially designed to
predict chronological age, there is evidence that the
epigenetic age also reflects biological age and is predictive
of functional decline [10–22]. This suggests that the
observed methylation signatures might be caused by an
intrinsic biological ageing process. One suggestion has
been that the methylation clock ‘measures the cumulative
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effect of an epigenetic maintenance system’ [6], a system
that is of critical importance and regulated at multiple
levels [23, 24]. As such, further insights into the mechanis-
tic properties of this underlying process are of key rele-
vance to understand ageing in more detail and will also be
instrumental for the design of future interventions. Conse-
quently, a methylation clock that is applicable to animal
models more amenable to experimental interventions
would be of considerable importance.
Importantly, while a very small number of age-
correlated methylation changes at selected sites in the
mouse genome have been reported [25], it is not known
whether such an epigenetic ageing clock is conserved
between species or a unique property of humans and
some closely related primates [6]. Given the general
occurrence of the ageing process across the animal
kingdom [1], differences in the mechanistic properties of
such a clock could explain differences in median lifespan
between closely related species. Here we have generated
high-resolution methylomes from the experimentally
tractable mouse across a wide range of tissues and ages.
We find that discrete DNA methylation changes correl-
ate with chronological age and are associated with bio-
logical functions. Based on these findings, we generated
a multi-tissue age predictor for the mouse, characterised
its properties, and demonstrated that it can be applied
to inform other studies by applying it to publicly avail-
able datasets, including key biological interventions.
Results and discussion
DNA methylation changes in mice correlating with age
In order to study age-associated DNA-methylation
changes in the mouse over a wide range of ages and
tissues, we collected liver, lung, heart and brain (cortex)
samples from newborn to 41-week-old mice (Fig. 1a). To
reduce genetic variability and hormonal variations, we
restricted our cohort to male C57BL/6-BABR mice and
sampled three to five animals per time point. In total, we
collected 62 samples (Additional file 1) and extracted
genomic DNA for methylation analysis from them.
We generated reduced-representation bisulfite sequen-
cing (RRBS) libraries of all samples to be able to assess
DNA methylation changes at a wide range of CG sites
and sequenced these to 15× genomic coverage on aver-
age. RRBS represents a good compromise between se-
quencing costs, CG sites measured and fold genomic
coverage obtained. To improve the quantification re-
sults, we optimised the standard RRBS library prepar-
ation protocol [26] and were able to achieve very low
duplication rates and high genomic coverage. On aver-
age, more than 1.23 million CG sites in each sample
were covered at least five-fold and of these 0.73 million
CG sites had more than five-fold coverage in all samples
analysed. Global CpG methylation levels in newborns
were around 43% and did not differ significantly between
tissues. In the older samples, average methylation levels
were slightly higher (~45%) but did not show major dif-
ferences between ages or tissues (Additional file 2A).
Global methylation levels measured by RRBS are
generally lower than whole-genome bisulfite sequencing
(WGBS) estimates, as the method enriches for hypo-
methylated CpG islands (CGIs) [26]. We also observed
low levels of non-CpG methylation in all non-brain tis-
sues (Additional file 2B). In agreement with the notion
that de novo methylation activity in non-dividing cells
results in accumulation of CHH methylation, we found
that adult cortex samples had higher CHH methylation
levels than newborn cortex samples [27]. Together our
samples represent the most comprehensive dataset thus
far of matched single base resolution methylomes in mice
across multiple tissues and ages. Importantly, a hier-
archical clustering analysis using Manhattan distances
(Additional file 2C) clearly separated the samples by tissue
(with the exception of newborn lung samples which clus-
tered together with adult heart samples), highlighting key
tissue-specific methylation signatures [28].
A correlation analysis showed that DNA methylation
at a substantial number of CG sites across all tissues
correlated with age (Spearman’s correlation, with a
multiple testing corrected p value < 0.05) (Fig. 1b and c).
As expected, the majority of these sites showed age-
correlated methylation changes in all or at least three tis-
sues (Additional file 2D), suggesting that age-dependent
DNA methylation changes at specific sites occur in a
coordinated manner across tissues. The correlation values
between age and DNA methylation at discrete CG sites
were both positive and negative and normally distributed
(Fig. 1d). Overall, we identified more positive correlations,
but this skewing is likely to be the result of the slight glo-
bal hypomethylation in the newborn samples and repre-
sents the general tendency for gain of DNA methylation
during development.
To understand whether the underlying sequence
composition or genomic context was relevant to the
changes observed, we analysed CpG density (Bonferroni
corrected two-tailed t-test, p value < 0.05) and genomic
context (Binomial test, p value < 0.05) at the significantly
correlating sites. While CpGs changing DNA methyla-
tion with age were on average in regions with higher
CpG density (lower CpG scarcity), the CpG density was
not predictive of the methylation changes (AUC = 0.58
or 0.61; see ‘Methods’ for details) (Fig. 1e). We also
found a strong depletion of sites with significant correla-
tions with age at CGIs and CGI rich promoters and con-
versely a strong increase at CGI-shores and CGI-shelves
(4 kb around CGIs) (Fig. 1f ). This indicates that tightly
controlled regulatory regions, such as CGIs, are rela-
tively protected from age-associated DNA methylation
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changes, while regions with intermediate CpG density
are more prone to changes. A Gene Ontology (GO) ana-
lysis of the genes closest (max. 4 kb distance) to CpGs
with highly significant positive age-dependent changes in
DNA methylation revealed a significant enrichment of
genes associated with the terms ‘anatomical structure
morphogenesis’, ‘anatomical structure development’ and
‘developmental process’ (Fig. 1g). Genes close to sites
with significant negative age-related correlations were
enriched in terms containing nucleotide and enzyme
binding. These results suggest that the age-related
changes in DNA methylation could alter various import-
ant biological processes and future experiments may re-
veal the regulatory relevance and association with gene
expression. In particular, increased DNA methylation at
developmentally relevant genes suggests that the ageing
process may restrict expression of developmental genes.
We next analysed age correlations in each tissue inde-
pendently and identified a large number of sites, which
showed exclusively tissue specific changes in DNA
methylation with age (Fig. 1h and Additional file 2E).
Interestingly, only a small fraction of these were shared
between three or more tissues, indicating that additional
age-related DNA methylation changes are characteristic
for each tissue and might relate to its intrinsic biological
function (Additional file 2F). In particular, GO analysis
of genes close to the sites with tissue-specific changes
revealed highly different GO term enrichments, indicat-
ing their unique tissue-specific regulation.
The marked differences between the global methylation
levels of newborn and adult samples (Additional file 2A)
prompted us to also analyse the datasets excluding new-
born samples (Additional file 3). A number of sites showed
a reversed directionality of age-dependent methylation
changes if we excluded the newborn samples from the ana-
lysis (highlighted in pink and green; Additional file 3A and
B); however, the majority of sites (highlighted in blue and
orange/red) showed the same correlation characteristics
independent of the inclusion or exclusion of newborn
samples (Additional file 3C). The correlations between age
and DNA methylation in the adult datasets were both posi-
tive and negative and the correlation values were normally
distributed (Additional file 3D), but none of the correla-
tions were significant (Additional file 3E; Spearman’s
correlation, with a multiple testing corrected p value cutoff
of < 0.05). Although the analysis was based on all tissues,
only a small number of the age-correlated methylation
changes in the adult samples were common to all tissues
(p < 0.005; Additional file 3F). A subsequent analysis of age
correlations in each tissue independently identified a large
number of tissue specific methylation changes (p < 0.005;
Additional file 3G and H), suggesting that changes in DNA
methylation in adults are primarily driven by tissue-
specific processes, while tissue-independent methylation
changes are associated with global developmental pro-
cesses (Fig. 1g).
DNA methylation levels at a discrete set of CpGs are
predictive of age
Having found that methylation at many individual CG
sites did change in an age-dependent manner, we decided
to generate an epigenetic age predictor in mice (Fig. 2a).
In addition to our own datasets, we also included previ-
ously published datasets comprising RRBS libraries from
liver, lung, muscle, spleen and cerebellum samples from
male and female C57BL/6 mice aged newborn to 31 weeks
[29–32]. An overview of these datasets can be found in
Additional file 4. In short, 129 healthy samples were used
to define the training set, with the remaining 189 making
up an independent test set, including two datasets that
were generated by different labs and hence experimentally
independent from the datasets used to train the model.
All samples were processed as described in the ‘Methods’.
We excluded CpGs located on either of the sex chromo-
somes or in the mitochondrial genome prior to further
processing and analysis.
We used an elastic-net regression model to predict
log-transformed chronological age, measured in days.
(See figure on previous page.)
Fig. 1 DNA methylation changes correlate with age. a Overview of the Babraham dataset. Ages of the mice are emphasised by colour. Tissues
(liver, lung, heart and cortex) were isolated from mice at four distinct time points (newborn, 14 weeks, 27 weeks and 41 weeks). DNA was isolated
from these tissues and reduced-representation bisulfite (RRBS) libraries were made. b Heatmap of the top 500 tissue independent age-associated corre-
lations. Highlighted are ages and tissues, CG sites were clustered by Euclidean distance. c Single CG sites within the genome are correlated with age.
Shown is an example site (chr8:120397660), with a Spearman correlation with age of 0.65. Tissues are highlighted by colour. Jitter is for aesthetic pur-
poses only. d Overview of Spearman correlations calculated over all tissues. The distributions of correlation estimates are shown in the histogram and
proportionate numbers of correlations are shown in the bar plot. Nominal correlations are highlighted (p value < 0.05) in light orange (positive) and light
blue (negative). Significant correlations are highlighted (q-value < 0.05) in orange (positive) and blue (negative). Numbers provided above the bar plot
represent the number of single CG sites within the given category. e Surrounding CpG content (± 500 bp) of the significantly correlated sites. Back-
ground was calculated from all CG sites with five-fold coverage in 90% of samples; CpG scarcity is defined as the average CpG distance within this 1
kb region. *Bonferroni corrected p value < 0.05. f Enrichment of a correlated CG site falling within a given genomic element. Background was all CG sites
with five-fold coverage in 90% of samples. Tested using binomial test; *p value < 0.05. g Gene Ontology (GO) analysis of the significantly correlated CG sites.
GO terms are plotted against –log(corrected p value). Positive correlations are shown in orange and negative in blue. The six most significant GO terms
are shown. h Tissue-specific Spearman correlations with age. An example is provided of a tissue-specific correlation with age in cortex, liver, lung and
heart. Correlations for these CG sites are provided for all tissues combined and for the tissue in question. Jitter is for aesthetic purposes only
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Only CG sites covered by at least 5 reads in all samples
were used (~18 k sites; see ‘Methods’ for details). Follow-
ing cross-validation to optimise the model parameters,
the final predictor was based on 329 CG sites
(Additional files 5A and 6); the sites in this predictor will
be referred to as mouse (multi-tissue) clock sites. The
model selects the most informative sites but allows for
some redundancy to increase robustness and it infers
weights for each individual site [33]. The model weights
across sites are depicted in Additional file 5B. One im-
plication of this approach is that the clock sites do not
necessarily represent the strongest age-correlating sites
characterised above (Fig. 2b). Similar to the human age
predictor described by Hannum et al. [5], the initial
starting methylation levels of the mouse clock sites are
somewhat predictive of the directionality of their methy-
lation changes with age (Additional file 5C).
As expected, the exponent of the weighted average of
the DNA methylation levels of the 329 selected CG sites
was highly correlated with (chronological) age of the in-
dividual samples within the training dataset (Fig. 2c).
Notably, using unobserved test samples, our mouse epi-
genetic clock was able to accurately predict chrono-
logical age in various tissues (Fig. 2d) and across
multiple independent datasets (Additional file 7A). The
accuracy of the model predictions was also independent
of sequencing depth of the test samples (Additional
file 7B), provided there was a mean coverage per CG site
of 5 reads or more. This indicates that minor technical
variations and coverage differences are well tolerated and
consequently our mouse epigenetic clock model can be
applied to a wide range of different settings. This was
evident by the fact that the predictor was able to
accurately estimate age in two completely independent
test datasets [31, 32] (Additional file 7C).
The mouse clock performed well across all tissues and
ages tested, with an age correlation of 0.839 and median
absolute error (MAE) of 3.33 weeks in the test data
(Fig. 2d and e), corresponding to less than 8.5% error
relative to the oldest ages (41 weeks) analysed. In order
to compare the accuracy with the human epigenetic
clock [6], we calculated the MAE as a proportion of the
expected lifespan of a mouse (>100 weeks) and found it
to be similar to that reported for the human clock
(assuming an average human lifespan of 85 years). It is
worthy of note that, similar to the human clock, the per-
formance of our mouse age-predictor varied between
young and old mice. In young animals (< 20 weeks), the
model predictions were much more accurate, with a
MAE of 2.14 weeks in the test samples. In mice aged 20
weeks or older, the MAE was 4.66 weeks (Additional
file 7D). We also attempted to include publicly available
WGBS datasets, including samples from 24-month-old
animals [34], to test our age predictor at older ages.
Unfortunately, the sequencing depth in most WGBS
datasets is significantly lower than in RRBS datasets (mean
coverage < 5-fold), thus precluding their analysis. It is
expected that future high coverage datasets will help to
further improve the accuracy of the mouse clock and test
its performance at older ages.
To get further insights into the architecture of our
multi-tissue age predictor, we performed a principal
component analysis (PCA) of the variation within the
329 selected sites in the training datasets. Ninety percent
of the observed variability was explained by 69 principal
components (PCs) (Additional file 7E), of which two
PCs (PC1 and PC13) displayed a clear age relation
(p < 0.05). PC1 captured age-dependent changes and
showed a good separation of samples by age; PC2 sepa-
rated liver samples from the other tissue samples (Fig. 2f
and Additional file 7F). This analysis highlights that the
major variation within the selected CG sites in the training
set is governed by numerous factors, including tissue type
and age. However, dataset effects (i.e. technical variations)
are not among the major drivers of variation.
Next, we characterised the clock sites in more detail.
The CG sites were distributed across all autosomes with
no specific enrichment in any chromosome (Additional
file 8A). Similar to the age-correlated CG sites, we found
a strong depletion over CGIs and CGI promoters but
also over non-CGI promoters (Additional file 8B), sug-
gesting that the clock sites were specifically depleted in
(See figure on previous page.)
Fig. 2 Prediction of chronological age from a mouse epigenetic clock. a Flow chart to illustrate the steps taken in defining the model and testing
it. Datasets are displayed as segments of a circle. They are coloured to correspond with later figures, namely: Reizel in brown (R), Cannon in green
(C), Babraham in purple (B), Zhang in pink (Z) and Schillebeeckx in light green (S). The two independent datasets are displayed as segments in a
separate circle to those datasets utilised for the training phase. The flow of methylation data is shown as colour-coded lines. Training occurs at
the node (screen) with the caption: ‘glmnet’. The chosen CG sites and their corresponding weighting are passed on to the prediction tool itself
(node with the caption: ‘epigenetic age predictor’. Test data enter this prediction tool and age predictions are outputted, as displayed by the
pocket watches exiting this node. b Scatter plot depicting weight of chosen clock sites against their age-associated correlation, blue are negatively
correlated sites and orange are positively correlated sites. c Training set ages as predicted by the model, x-axis shows the actual age and y-axis
shows the predicted age, coloured by tissue. Jitter is used to represent the experimental error in age estimates. d Test set ages as predicted by
the model, x-axis shows the actual age and y-axis shows the predicted age, coloured by tissue. e Box plot of the absolute error in the training (left)
and test (right) samples. The median absolute error is indicated. f Principal component representation of the sites used in the clock, coloured by
age in weeks
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regulatory regions. CGI shores and intergenic regions
showed increased enrichment in clock sites, whereas the
CpG density around the clock sites did not show any
differences compared to other random CG sites (Add-
itional file 8C). The 329 clock sites did also not show
any specific GO enrichment (not shown), suggesting that
the sites selected by the model might not represent a
unique biological function and are instead associated
with various biological functions.
Age predictions using the human clock sites in mouse
Given the similarities between our mouse epigenetic age
predictor and the previously described human epigenetic
clock [6], we asked whether the specific genomic loci de-
scribed in human could be used to predict age in mouse
samples too. First, we attempted to lift over the genomic
locations of the 353 human clock sites to the mouse, by de-
fining regions ± 500 bp around the sites. We were able to
lift over 328 regions, of which 175 regions (in the following
referred to as ‘Horvath clock regions in mouse’) were cov-
ered by at least one CG site in our dataset. Methylation
levels at these 175 Horvath clock regions in mouse were
only weakly correlated with age (Additional file 9A), which
is also true for the Horvath clock sites in human [6].
Next, we assessed whether the 175 Horvath clock re-
gions in mouse could be used for age prediction. Using a
ridge model, we were able to generate an age prediction
model with a MAE of 11.2 weeks (Fig. 3), indicating that
the methylation levels at the 175 Horvath clock regions
in mouse contain age-related information and are pre-
dictive of age in the mouse. The directionality of the
mouse-specific and human-specific weighting for any in-
dividual CG site within the Horvath clock regions in
mouse were completely unrelated (Additional file 9B),
suggesting that the human clock [6] is not fully
conserved in mouse. Remarkably, we found that we
could also generate age prediction models from matched
random regions (see ‘Methods’ for details) with an
average MAE of 10.6 weeks (Fig. 3), highlighting the fact
that methylation changes in many genomic regions are
age-related and potentially predictive.
In summary, the predictive accuracy of the sites corre-
sponding to the human clock in mouse samples was sig-
nificantly lower than our mouse epigenetic clock. These
differences are in part due to technical differences in de-
fining the clock sites, but do also highlight species-specific
differences, which result in different age-dependent
methylation changes at discrete loci and might point to
different ‘ticking’ rates of human and mouse ageing.
DNA methylation age is altered in ovariectomised females
and by diet
Given the accuracy of our mouse epigenetic clock to
predict chronological age in healthy individuals, we
asked whether epigenetic age in the mouse would be af-
fected by gender, diet or other biological interventions.
Since it has been reported that DNA methylation shows
gender-specific patterns [30], we compared the predicted
DNA methylation age of female and male mice.
Although the training data were predominantly com-
posed of male samples (> 72%), we did not find signifi-
cant differences in the estimated ages between sexes
(Fig. 4a and Additional file 10), highlighting the robust-
ness of the model and showing that gender-specific dif-
ferences are not skewing the predictions of the mouse
epigenetic clock.
We next analysed publicly available RRBS datasets of
samples with various biological interventions [29, 30].
Overall the epigenetic age predictions were well related
to the true chronological age of the individual mice
(Fig. 4b), but at closer inspection we identified important
differences, which depended on treatment.
Reizel et al. performed ovariectomy in females, treated
the mice with testosterone (5 mg/mL) or vehicle [30]
and analysed their liver DNA methylome by RRBS.
Ovariectomy decreases average lifespan in female rats
[35] and indeed we found that ovariectomy increased
epigenetic age significantly in mice (Fig. 4c). Additional
testosterone or vehicle treatment had no significant ef-
fect on the epigenetic age and was also shown to not
alter lifespan in rats [35]. This suggests that hormonal
differences in mice affect ‘biological age’, as measured by
Fig. 3 Prediction evaluation of the human Horvath clock sites in
mouse. Shown is the MAE of the age prediction model generated
using the lifted-over human clock sites [6] (red line). The distribution
(blue) shows the MAEs of 1000 age-prediction models generated using
random selections of 329 regions (see ‘Methods’ for further details)
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our mouse epigenetic clock; similarly in humans, breast
tissue is found to have accelerated epigenetic ageing [6].
In a second study, Cannon et al. [29] characterised the
effects of lipid content in maternal and offspring diet on
body weight, physiology and DNA methylation status in
the liver and reported a significant effect of maternal
diet on the susceptibility of the offspring to become
obese and develop signs of metabolic disease. The great-
est adverse effects were observed when the mothers
were fed a low-fat diet and the offspring a high-fat diet.
By applying our mouse epigenetic clock to these liver
samples, we identified a strong dependency of the pre-
dicted epigenetic age on diet (Fig. 4d). Offspring on a
high-fat diet showed accelerated epigenetic ageing,
which had a tendency to be further exacerbated if the
mothers were fed a low-fat diet. This result suggests that
biological ageing is modulated by diet and possibly inter-
generational or transgenerational effects and that epi-
genetic age is a potential powerful measure of biological
function.
Conclusions
In this study, we have generated the thus far most com-
prehensive set of matched single base resolution methy-
lomes in mice across multiple tissues and ages. This
resource allowed us to study the correlation between
DNA methylation changes and ageing in detail. Import-
antly, we were able to establish, for the first time, a mouse
epigenetic clock, which estimates age based on the methy-
lation state at 329 discrete CG sites throughout the mouse
genome. Our novel epigenetic clock is performing similar
to the human epigenetic clock and allowed us to assess
(epigenetic) age in unrelated methylation datasets. Worthy
of note, the 329 sites of our mouse epigenetic clock
perform significantly better in predicting age in mouse
samples than the sites in the mouse genome correspond-
ing to the human Horvath clock sites. So far, our epigen-
etic clock has been developed and tested from tissue
samples up to 41 weeks of age and future experiments
and datasets will be required to assess its accuracy in older
mice. The epigenetic clock and the comprehensive set of
methylomes are available to the ageing research commu-
nity and will enable mechanistic and intervention studies
in the experimentally tractable mouse model system.
Importantly, we found that the mouse methylation
clock is affected by biological interventions and as such
we suggest that the prediction of the clock reflects not
only chronological age but also biological age. It will be
exciting to test the consequences of manipulations of
the ticking rate of the epigenetic clock on biological
function, in particular the possible reversibility of ageing
associated functional decline. We believe that this work
will help scientists gain insights into the biology of age-
ing and potentially help to discover novel strategies to
extend lifespan and health span in the future.
Methods
Babraham Institute C57BL/6 J/Babr Ageing Mouse Colony
Mice were bred and maintained in the Babraham
Institute Biological Services Unit (BI BSU) under Specific
Opportunistic Pathogen Free (SOPF) conditions. C57BL/6
J mice (supplied by Charles River Laboratories) were
imported into the BI BSU by embryo transfer and bred
there (/Babr) as a SOPF colony in plastic film isolators.
After weaning, male mice were transferred to individually-
ventilated cages in groups of between two and five mice.
All mice were fed CRM (P) VP diet (Special Diet Services)
ad libitum and received sunflower seeds, poppy seeds or
millet at cage-cleaning as part of their environmental en-
richment. The health of mice was monitored closely and
any mouse exhibiting clinical signs of ill-health or distress
that persisted for more than three days was culled. In this
way, all the mice maintained remained ‘sub-threshold’
with respect to the UK Home Office severity categorisa-
tion. Maintained, assessed and defined in this way, mice in
this ageing colony remained healthy for a median period
of approximately 99 weeks. Clinical signs necessitating
culling included dermatitis (excessive scratching), fight
wounds and muscle weakness, among several others.
Post-mortem analysis sometimes revealed neoplasias (es-
pecially lymphomas and haemangiosarcomas) typical of
this strain. Any mice exhibiting any gross pathology upon
post-mortem examination was excluded from this study.
Sample collection: Babraham dataset
Cortex, heart, liver and lung samples from the Babraham
Institute C57BL/6 J/Babr ageing mouse colony were
collected at four different ages: newborn (<1 week), 14
(See figure on previous page.)
Fig. 4 Methylation age is affected by biological interventions. a Predicted age of 20-week-old liver samples [30], shown separately for males and
females. Statistical test performed: t-test, p value of 0.58. b Age prediction in test samples from various biological intervention studies. X-axis
shows the actual age and y-axis shows the predicted age, coloured by study. c Age prediction in normal female liver samples and samples which
underwent an ovariectomy and were administered with either vehicle alone or testosterone [30]. Statistical test performed: Unpaired two-tailed
t-test performed to assess the impact of ovariectomy, p value of 0.014. d Age prediction in diet perturbation study [29]. Liver samples from
animals with following treatments were analysed: maternal high fat diet followed by adult high fat diet, maternal high fat diet followed by
adult low fat diet, maternal low fat diet followed by adult high fat diet, and maternal low fat diet followed by adult low fat diet. Statistical test
performed: two-way ANOVA performed, p values displayed where significant
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weeks, 27 weeks and 41 weeks. All tissues were snap-
frozen directly after isolation. Genomic DNA was iso-
lated from ~10 mg frozen tissue using the DNeasy Blood
& Tissue Kit (Qiagen). A total of 62 samples were col-
lected, processed and further analysed. The resulting
dataset are referred to here as Babraham dataset.
Library preparation
RRBS libraries were prepared from isolated DNA follow-
ing published protocols [36]. Briefly, RRBS libraries were
prepared by MspI digestion of 100–500 ng genomic DNA,
followed by end-repair and T-tailing using Klenow Exo-
(Fermentas). Adapter ligation was performed overnight
(in-house adapters) using T4 DNA Ligase (NEB), followed
by a clean-up step using AMPure XP beads (Agencourt,
0.9×). Subsequently, libraries were bisulfite-treated ac-
cording to the manufacturer’s instructions (Sigma Imprint
Kit; 2 step protocol) and purified using an automated
liquid handling robotic system (Agilent Bravo). The librar-
ies were amplified using KAPA HiFi Uracil HotStart DNA
Polymerase (KAPA Biosystems), indexing the samples
with individual primers. All amplified libraries were puri-
fied (AMPure XP beads, 0.8×) and assessed for quality
and quantity using High-Sensitivity DNA chips on the
Agilent Bioanalyzer. High-throughput sequencing of all
libraries was carried out with a 75 bp paired-end protocol
on a HiSeq 2000 instrument (Illumina).
Methylation data processing
For datasets generated in this study, raw paired-end FastQ
files were pre-processed to remove the first 13 bp from
their 5’ ends, containing unique molecular identifiers (UMI)
sequence tags. Both Read 1 and Read 2 UMIs and fixed se-
quences were written into the read IDs. These trimmed
reads were then subjected to adapter and quality trimming
with Trim Galore (http://www.bioinformatics.babraham.
ac.uk/projects/trim_galore/; v0.4.2; options: –paired –
three_prime_clip_R1 15 –three_prime_clip_R2 15, to also
remove potential UMI and fixed tag sequences from the 3’
ends). The trimmed files were then aligned to the mouse
genome (GRCm38) using Bismark [37]; v0.16.3, default
parameters). The mapped sequences were deduplicated by
chromosomal position as well as the UMI sequences of
both Read 1 and Read 2 (no mismatches tolerated) using
the tool UmiBam (https://github.com/FelixKrueger/
Umi-Grinder; v0.0.1; options: –bam –dual_umi). These
UMI-deduplicated BAM files were then further processed
with the Bismark Methylation Extractor (default parameters)
to yield Bismark coverage files.
Calling of methylation at single CG sites
Mean methylation levels of each CG site covered in each
sample were calculated from the Bismark coverage files.
In addition, a read count was conducted for each CG
site in each sample, so that filtering could be done based
on this information in downstream analysis.
Statistical analysis of age association at single CG sites
For the statistical analysis presented in Fig. 1, we first fil-
tered site that had a mean coverage of < 2 reads or > 100
reads. This was done to remove spurious reads from
library preparation and potential mapping artefacts. For
the remaining sites, any site that was covered with < 5
reads in a sample was replaced with NA. Before cal-
culating age association, we further filtered for sites,
such that the sites were at least covered in 90% of
samples (n = 1,921,569). Ages in days were used when
computing the Spearman correlation for each site using
the R implementation of the Spearman correlation and
multiple testing correction was performed using the
Q-value package [38]. For the tissue-specific analysis, a
further filtering step was conducted to ensure that there
were at least four samples being considered for each
correlation test. For data exploration, we used PCA
analysis, on sites (n = 729,785), which were covered in all
samples at 5×.
Predicting significance of age relation based on CpG
density
To assess if CpG density is predictive of the methylation
age relations, we tried to predict if a relation between
age and methylation level would be significant based on
CpG density. To do so, we used CpG density as a linear
predictor using multiple thresholds to predict if a
methylation age relation would be significant or not
using the AUC function for the pROC library [39].
Genomic enrichment analysis of significant
age-associated sites
Normalised likelihood was calculated as:
Normalised likelihood; at x ¼ s
b
 B
S
 
−1
where:
s = number of significant sites at a given x
S = total number of significant sites
b = number of background sites at a given x
B = total number of background sites
CpG scarcity
CpG scarcity was calculated as:
CpGscarcity ¼ 200
no:of CG siteswitina200bp; centered onaCpGof interest
GO analysis of neighbouring genes
Neighbouring genes were defined for single CG sites
that were within 4 kb of a gene. GO terms were defined
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using the gprofiler online software [40]. For the GO en-
richment analysis, a background gene list was made con-
sisting of the neighbouring genes (max distance of 4 kb)
for all sites considered in that analysis. Significant GO
terms were ordered by p value and the top six GO terms
are shown.
Human-comparative analysis
We defined 1 kb windows around the 21 k CpG sites
that are interrogated in both the 27 k and 450 k Methy-
lArray [6], to ensure that the sites could be faithfully
lifted over. These sites were then lifted over from the
human genome to the corresponding regions in the
mouse genome (GRCm38). In particular, 91% of the sites
selected by Horvath [6] for the human clock were suc-
cessfully lifted, i.e. 329 of 353. To be able to contrast the
human Horvath clock sites [6] to other sites in the
mouse genome, we chose to use all ~21 k sites, of which
we were able to lift over 19 k regions. 175 regions corre-
sponding to the 353 clock sites and 10 k regions corre-
sponding to all ~21 k sites were covered in the
Babraham dataset. Adding additional datasets (e.g. Reizel
et al. [30]) reduced the number of regions covered
dramatically.
Using these sites, we first assessed the age association by
comparing the correlation to age in the Horvath clock
regions verses random selections of all lifted-over regions.
After this we built an age prediction model based on the
175 covered regions corresponding to the Horvath clock
sites. For this, we built a ridge model as implemented in
glmnet, by fixing the alpha parameter to 0. The predictor
reaches a MAE of 11.2 weeks. To compare this to back-
ground, we built a thousand random models, picking a
random set of 329 regions, regardless of coverage, from
the 19 k regions we could lift over. The average MAE was
10.65 weeks in these random models.
Predicting age in mice
Dataset overview (see Additional file 1)
For defining a more generalizable age predictor, we
included four additional external RRBS datasets, which
were downloaded from the GeneExpressionOmnibus
(GEO) database (https://www.ncbi.nlm.nih.gov/geo/):
Reizel et al. [30] (GSE60012; n = 173); Cannon et al. [29]
(GSE52266; n = 40); Zhang et al. [31] (GSE80761; n = 4);
and Schillebeeckx et al. [32] (GSE45361; n = 23). The
datasets were processed in the following manner: Raw
FastQ files were trimmed with Trim Galore (v0.4.2; pa-
rameters: –rrbs) and then aligned to the mouse genome
(GRCm38) with Bismark (v0.16.3; default parameters).
The aligned BAM files did not undergo deduplication but
were processed directly with the Bismark Methylation
Extractor (default parameters) to yield Bismark cover-
age files.
In the following sections a short description of the
dataset is given.
Reizel et al. [30]
The Reizel study consists of 173 samples originating
from four different tissues: liver, muscle, cerebellum and
spleen; data were collected at six time points ranging
from 1 to 31 weeks. In the original study, gender and tis-
sue specificity of demethylation during ageing has been
studied. In the study, a perturbation based on castration
and restoring testosterone levels after castration has
been performed. For the development of the methylation
clock, the perturbations were not taken into the training;
these were left for the test-set. Further information can
be found in Additional file 1 and the original publica-
tion. After QC, there were 143 samples left.
Cannon et al. [29]
The Cannon study consists of 40 samples all originat-
ing from liver at the age of nine weeks. In the original
study, the effect of maternal diet on the metabolism of
adult offspring was studied. In our study, we selected
part of the data to be in our training set to reflect the
nine-week time point (n = 5). The other part of the data
is used to assess the effect of diet on ageing. Further
information can be found in Additional file 1 and the
original publication. After QC, there were 36 samples left.
Zhang et al. [31]
The Zhang study consists of four samples all originating
from liver at the age between six and eight weeks. In the
original study, methylation differences between different
strains of mice, and the difference between mouse and zeb-
rafish DNA-methylation levels are assessed. In our study,
these samples were used as a validation to see how the pre-
dictor works for an unobserved time point. The age of
these mice has been set to seven weeks in our study. Fur-
ther information can be found in Additional file 1 and the
original publication. After QC, there were four samples left.
Schillebeeckx [32]
The Schillebeeckx study consists of 23 samples all ori-
ginating from the liver, the adrenal gland and from endo-
metrial cancer. The mice were ovariectomised at the age
of three to four weeks; samples were collected after an
additional three months. In the original study, a laser cap-
ture microdissection RRBS method was introduced. For
our study, we selected the liver samples, which were gen-
erated using normal RRBS; after QC, three samples were
left. In our study, these samples were used as a validation
to see how the predictor works for an unobserved time
point. The age of these mice has been set to 16 weeks in
our study. Further information can be found in Additional
file 1 and the original publication.
Age prediction
To predict the mouse age, we adopted a similar ap-
proach to those utilised in human studies [5, 6], namely
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an elastic-net regression model. First, we intersected the
sites, which were available with more than five-fold
coverage in all training and test samples used, totalling
to 17,992 sites. By selection of the sites available in all
datasets, we hope to have selected a set of methylation
sites, which will be present in most RRBS studies, irre-
spective of size selection and data handling. In addition,
we filtered out both sex chromosomes (X and Y) and
the mitochondrial genome to ensure that the model
would not be sex-specific nor hampered by the
unreliability of mitochondrial genome bisulfite conver-
sion. After selection of the sites and samples, we have
used a quantile normalization to normalize the methyla-
tion values, followed by a standardization, putting the
mean methylation per site to 0 and the standard devi-
ation to 1.
For the predictor, we used the elastic-net generalised
linear model as implemented in the GLMNET package
[33]. To optimise the alpha, defining the elastic net
mixing parameter (1 for lasso to 0 for ridge) and to
optimise the lambda, the regularisation parameter, we
used a double-loop cross-validation setup. This setup is
described in Ronde et al. [41]. We have trained the model
to predict the log transformed mouse age (in weeks); three
weeks were added before log transforming the ages to be
able to predict samples pre-birth.
For the training set we selected 129 healthy samples
from the Babraham, Reizel and Cannon studies; sample
details are in Additional file 4. By using an internal ten-
fold cross-validation, in the inner loop the optimal alpha
(0.05) and optimal lambda (0.93) were identified. In the
outer loop the actual performance of the predictor was
scored (as assessed by the mean squared error). After
the cross-validation in the training, we built the final
model on all 129 samples to get our final model. To get
to our final model, we have taken the betas as derived
from GLMNET for the selected sites (329) and trained a
quadratic function using the nls function in R to trans-
form the raw prediction scores (sum of the product of
the beta weights multiplied by their respective methyla-
tion level) to the log age in weeks. The final function
used is:
log ageð Þ ¼ 0:1207x2 þ 1:2424xþ 2:5440
where x is the summed beta score per sample.
A set of healthy and treated samples, originating from
the same three studies, and the Schillebeeckx and Zhang
studies were used to assess the usability of the final
model. The MAE of the prediction was found to be 3.33
weeks. Furthermore, the model has been used to assess
the influence of diet on the methylation age, using the
Cannon training samples and the influence of male and
female castration on the methylation age.
MouseEpigeneticClock script
To predict methylation age from new samples we have
generated an easy to use R project and deposited it under
GNU General Public License at Zenodo [42] and as a
GitHub project: https://github.com/EpigenomeClock/
MouseEpigeneticClock.
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